These findings suggest that PCa radioresistance involves multifactorial traits, and targeting identified proteins or signaling pathways, primarily through ALDOA downregulation, in conjunction with radiotherapy holds promise for overcoming PCa’s radioresistance [114]. This evidence concerns the gene ALDOA and posterior cortical atrophy.